Acoustic Sculpting Platform
Not Specified (Likely neurological/soft tissue ablation)
Pre-clinicalActive
Key Facts
Indication
Not Specified (Likely neurological/soft tissue ablation)
Phase
Pre-clinical
Status
Active
Company
About Petal Surgical
Petal Surgical is developing a transformative, non-invasive surgical platform based on Millisecond Pulse Histotripsy, which causes Acoustic Liquefaction of tissue. Founded in 2019 by a team with deep expertise in neurosurgery, robotics, and medical device innovation, the company is backed by notable investors and advisors, including pioneers from Intuitive Surgical. Petal's technology targets the significant global burden of surgical complications and access limitations, positioning it to potentially disrupt multiple therapeutic areas within minimally invasive surgery. The company is currently in a pre-clinical, pre-revenue stage, advancing its platform toward clinical application.
View full company profile